Wednesday, July 8, 2026

pharma · T2DM (Type 2 Diabetes Mellitus) · Type 2 Diabetes Mellitus · ORMP

Oramed Pharmaceuticals

Oramed Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL HQ
2006 Founded
16 Employees
Public company Type
ORMP · NYSE Ticker
Company details
Status
Public
HQ
20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL
Founded
2006
Employees
16
Programs
14
Drugs
8
Patents
10
Intelligence · Clinical Trials

Oramed Pharmaceuticals clinical trials

Registry index of 16 ClinicalTrials.gov studies linked to Oramed Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Oramed Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Oramed Pharmaceuticals.

  1. Oral Insulin — Phase 2

    Clinical update
  2. ORMD-0801 (qd) — Phase 3

    Clinical update
  3. ORMD-0801 Treatment A — Phase 2

    Clinical update
  4. ORMD-0801 QD — Phase 2

    Clinical update
  5. ORMD-0801 (Insulin) capsule 8 mg BD — Phase 2

    Clinical update
  6. ORMD-0801 Dose # 1 — Phase 2

    Clinical update
  7. ORMD-0801 Capsules — Phase 2

    Clinical update
  8. ORMD-0801 capsules- 2x8mg — Phase 2

    Clinical update

Trial registry

16 studies